Skip to main content
Top
Literature
1.
go back to reference Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L, Ambresin A (2009) Intravitreal ranibizumab (Lucentis(R)) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol April 29 [Epub ahead of print], doi:10.1007/s00417-009-1089-3 Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L, Ambresin A (2009) Intravitreal ranibizumab (Lucentis(R)) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol April 29 [Epub ahead of print], doi:10.​1007/​s00417-009-1089-3
2.
go back to reference Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, Ladas ID (2009) Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: A prospective study. Retina 29:536–544CrossRefPubMed Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, Ladas ID (2009) Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: A prospective study. Retina 29:536–544CrossRefPubMed
Metadata
Title
Optimal treatment of retinal angiomatous proliferation
Authors
Lazaros Konstantinidis
Leonidas Zografos
Irmela Mantel
Aude Ambresin
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 2/2010
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1159-6

Other articles of this Issue 2/2010

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2010 Go to the issue